Latest journal
All journals
May 2022
Climate change poses a fundamental threat to our livelihood and addressing the crisis through the reduction of carbon pollution is vital. The National Health Service (NHS) in the UK has committed to reducing the carbon footprint from inhaler devices by 50% by 2030, primarily through a reduction in the use of pressurised metered-dose inhalers (pMDI). The development of pMDIs utilising lower global warming potential propellants by 2025 is currently underway. This article focuses on the need to apply an individualised approach for patient outcomes whilst minimising the carbon footprint of their inhaler treatments.
Latest articles
All articles
Watch this webinar to learn more about the latest insights in diagnosing and managing wheeze. Watch now:… twitter.com/i/web/status/1…
Posted 12 May
Last call to register for this educational webinar! The expert speakers will explore the current management of EGFR… twitter.com/i/web/status/1…
Posted 11 May
Join us today at 15:00 CEST to learn more about the unmet needs of patients living with EGFR-mutated Non-Small Cell… twitter.com/i/web/status/1…
Posted 11 May
Join us for a virtual webinar on the current and Future Management of EGFR-positive Non-Small Cell Lung Cancer (NSC… twitter.com/i/web/status/1…
Posted 09 May
In this episode, we delve into some of the key insights provided by our guests, as well as other notable conversati… twitter.com/i/web/status/1…
Posted 28 April